Key Information
ISIN: | GB00B15FS791 |
Exchange: | Main Market, London Stock Exchange (listed on the standard segment of the official list) |
Par: | 0.01p |
Inst Type: | ORD |
Symbol: | MNRG |
MiFID Status: | MTF |
Issued Shares: | 371,409,433 |
Sector: | Financial Services |
Directors' Shareholdings:
updated as at 17/9/2020
371,409,433 Ordinary shares are held in public hands representing 80.88% of issued share capital.
Name | Number of Ordinary Shares | % of Issued Share Capital |
---|---|---|
Christopher Latilla-Campbell (Chairman)(*) | 39,373,775 | 10.60% |
Rolf Gerritsen (CEO) | 14,150,000 | 3.81% |
Christian Schaffalitzky (NED) | 7,933,333 | 2.14% |
Pierpaolo Rocco | 8,288,555 | 2.23% |
Total director holdings | 69,745,663 | 18.78% |
(*) Christopher Latilla-Campbell’s interests includes 24,750,000 shares held by Buchanan Trading Inc, in whose shares he is deemed to be interested, as he is a potential beneficiary of a discretionary trust which controls it.
Outstanding Director Options:
Expiring 30 April 2021: | Number of Ordinary Shares | Exercise Price |
Rolf Gerritsen (CEO) | 5,000,000 | 3p per share |
Outstanding Warrants:
Number of Ordinary Shares | Exercise Price | |
Expiring 30 March 2021: | 2,500,000 | 3p per share |
Expiring 20 November 2020: | 9,700,000 | 2p per share |
Expiring 23 July 2021: | 89,333,326 | 0.6p per share |
Pursuant to his equity investment in the Company as announced on 23 February 2018, on completion of his investment Rolf Gerritsen will be issued with 2,500,000 warrants. The warrants will have a term of 36 months from the date of grant and will be exercisable at 3p per share.
Effect of options and warrants exercise:
Should all the outstanding options and warrants outlined above be exercised the Company will receive additional funds of £955,000 and the fully diluted Ordinary Shares in issue will total 471,276,093 Ordinary Shares
Convertible Loan Notes (“CLNs”)
In addition to the Options and Warrants, the Company has issued £375,000 of fixed rate (10% per annum) unsecured CLNs with an expiry date of 31 January 2021. The CLNs are repayable, if not previously converted, on 31 January 2021.
Holders of the CLNs may convert them into new MetalNRG Ordinary Shares at a price of 0.6 pence per share or at 85% of the average published volume weighted average share price over the 10 trading days prior to conversion at any time prior to or on 31 January 2021.
If the CLNs were to be converted into new MetalNRG Ordinary Shares at 0.6p per share a further 62,500,000 Ordinary Shares would be issued.